Aim-This study was set
Results-Peripheral retinal vascular changes were common, and a qualitatively abnormal vascular border believed to imply risk of proliferative sickle retinopathy (PSR) was significantly more common in south western SS patients and PSR was shown in one of these. There were no differences in visual acuity, the presence of peripheral retinal patches, or the circumferential or posterior extent of peripheral retinal vessel closure between SS disease and sickle cell PO thalassaemia or between SS disease in the two regions. Compared with the Jamaican Cohort Study, >1800 of the peripheral retinal vasculature was seen significantly less frequent, suggesting factors inhibiting vascular remodelling in Saudi patients in early life. Conclusion-Sickle cell disease in Saudi Arabia affects the retina and represents a potential threat to vision. Changes occur whatever the haplotype, and is similar to that observed in Jamaica. (BrJ Ophthalmol 1995; 79: 457-461) Sickle cell disease in Saudi Arabia presents interesting and instructive differences from that observed in populations of African origin. The mutation in the south west of the kingdom is of the Benin haplotype, is probably imported from Africa, and has similar levels of fetal haemoglobin (HbF) to those observed in African patients with the same haplotype.1 In the eastern province, there has probably been an independent mutation of the sickle cell gene, the so-called Asian haplotype,2 which is associated with higher levels of HbF. 
Results
Retinal vascular changes were identified in this study which were similar qualitatively to those seen in the Jamaican cohort comprising fresh vascular obstruction (Fig 1) The regional differences in haematology imply that analysis of the relation between eye variables and haematology should take region into account using analysis of variance.
Subjects with >1800 of the anterior border seen had a lower HbF compared with those with -1800 (Table 2 ). The relation between the extent of the border seen and a thalassaemia (heterozygous and homozygous forms combined) appeared to differ in the two Comparison with the Jamaican cohort study should be treated with caution because of the difference in mean ages (27-7 years for Saudi patients, 17-8 years for Jamaicans), and the Saudi patients were not derived from unselected population base. In Jamaican subjects the extent of vascular border seen was greater, despite their younger mean age, suggesting a factor inhibiting vessel closure in both regions of Saudi Arabia in early life.5 This factor is unlikely to be the frequency of high HbF levels or ox thalassaemia since these did not differ between south western Saudi and Jamaican patients. Furthermore, the type IIa border was more common in south western than Jamaican patients, possibly reflecting the greater mean age of south western Saudi patients, a specific risk factor, or the symptomatic bias inherent in patients attending a tertiary referral hospital. The greater prevalence of an unstable type IIa border may be relevant for visual prognosis since this border implies threat of PSR which may in turn lead to visual loss. By contrast, a type I border, however posteriorly placed, is not followed by this complication and may be protective of proliferative disease. 5 Overall, despite minor differences, the ocular pathology in SS patients from each region of Saudi Arabia and differed little from that observed in Jamaicans with SS disease. That this is the case despite differences in haematological variables and clinical features should not be surprising, since visually threatening retinal vascular disease is seen most commonly in forms of sickle cell disease which may otherwise be relatively mild. Although no case in this study had lost vision as a consequence of their haemoglobinopathy, the number of cases was small, and it is likely that SS disease represents a threat to vision in Saudi Arabia albeit small. The more florid retinal pathology often observed in Jamaican patients is generally attributable to sickle cell haemoglobin C (SC) disease or sickle cell P+ thalassaemia which were not encountered in Saudi Arabia.5
